| Myocardial Infarction, year of event |
21,172 |
[25] |
| Myocardial Infarction, subsequent years |
3311 |
[25] |
| Angina, year of event |
4565 |
[26] |
| Angina, subsequent years |
2130 |
[26] |
| Congestive heart failure, year of onset |
20,280 |
[25] |
| Congestive heart failure, subsequent years |
5686 |
[25] |
| Stroke, year of event |
28,838 |
[25] |
| Stroke, subsequent years |
4001 |
[25] |
| Stroke death within 30 days |
11,104 |
[25] |
| Peripheral vascular disease, annual |
6869 |
[25] |
| Hemodialysis, annual |
87,468 |
[26] |
| Peritoneal dialysis, annual |
61,952 |
[26] |
| Renal transplant, year of event |
111,407 |
[26] |
| Renal transplant, subsequent years |
111,407 |
[26] |
| Laser eye treatment |
710 |
[26] |
| Severe vision loss/blindness, year of onset |
3542 |
[26] |
| Severe vision loss/blindness, subsequent years |
2525 |
[26] |
| Cataract extraction |
5315 |
[28] |
| Cataract treatment, subsequent years |
2963 |
[26] |
| Neuropathy, each year |
212 |
[26] |
| Standard uninfected ulcer |
1495 |
[26] |
| Infected foot ulcer |
3131 |
[26] |
| Gangrene treatment |
11,190 |
[26] |
| Amputation, year of event |
11,030 |
[28] |
| Amputation, prosthesis |
6156 |
[26] |
| Severe hypoglycemic event requiring medical assistance |
2262 |
[25] |
| Severe hyperglycemic event (diabetic ketoacidosis) |
12,160 |
[26] |
| Annual cost aspirin |
60.55 |
[26] |
| Annual cost statins (20 mg) |
383 |
[29] |
| Annual costs ACE inhibitor (ramipril 5 mg) |
86.62 |
[29] |
| Annual costs stopping ACEs due to adverse events |
84.55 |
[27] |
| Costs of screening for retinopathy |
90.13 |
[27] |
| Costs of screening for microalbuminuria |
33.86 |
[26] |
| Costs of screening for gross proteinuria |
33.86 |
[26] |
| Costs of foot screening program |
84.55 |
[27] |